FDA Inspection
Blood Assurance IncBlood Assurance Inc – FDA Inspection, Apr 25, 2017
Record Details
This FDA Inspection record concerns Blood Assurance Inc, with an inspection on April 25, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ef5af438-1a88-4659-b25d-10e5455f2061
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1009367
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 630.10(g)(1)Proof Of Identity
- 21 CFR 606.40(a)(1)Provide space for examination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Blood Assurance Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 1, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 15, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 2, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 28, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 4, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Blood Assurance Inc
- FDA Inspection 1222371 - 2023-11-01
- FDA Inspection 1079400 - 2019-02-15
- FDA Inspection 920630 - 2015-04-02
- FDA Inspection 815739 - 2013-01-28
- FDA Inspection 715735 - 2011-03-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.